How £513,000 is supporting 21 MS organisations through the pandemic

13th August 2021

Six months into the COVID-19 Response Initiative

MSIF puts a spotlight on the ethical use of off-label disease modifying therapies for MS

13th August 2021

New publication from MSIF on ethical use of off-label DMTs receives global endorsement

The MSIF movement shapes the WHO’s global action plan for epilepsy and other neurological disorders

11th August 2021

MSIF highlights priority actions for MS in the draft global plan

Tawasol – August 2021 issue

10th August 2021

The latest news from MS organisations in the Arab region

We’re hiring! HR and Office Manager

5th August 2021

MSIF's team of 20 seeks enthusiastic individual with an aptitude for developing & implementing supportive policies, practices…

May 50K wins the day!

29th June 2021

Time for a victory lap, The May 50K fundraisers have raised £1.25 million this year!

Answering questions on progressive MS treatment and research

29th June 2021

Watch the International Progressive MS Alliance webcast

EME in Spain welcomed as MSIF’s newest member

29th June 2021

Esclerosis Múltiple España is now an associate member of the MS International Federation

Not long until World Brain Day – find out what it’s all about

29th June 2021

22 July – join the conversation this World Brain Day

FDA backs further research into ‘neurofilament light chain’

29th June 2021

The regulatory agency’s Letter of Support will stimulate more studies that advance development and validation of the…

Professor Alan Thompson wins the prestigious MS Charcot Award

18th June 2021

Professor Thompson wins the 2021 lifetime achievement award for outstanding research into the understanding and treatment of…

Alliance funds 19 Research Challenge Awards looking for answers on progression

27th May 2021

In time for World MS Day, €1,425,000 has been awarded to help identify new therapeutic targets in…